BIOSIMILAR

BIOSIMILAR

Displaying 10 out of 10 results

  1. FILE PHOTO: Logo of U.S. pharmaceutical corporation Pfizer Inc. is seen in Zurich

    FDA approves Pfizer's biosimilar to Roche's Herceptin

    The U.S. Food and Drug Administration said on Monday it approved Pfizer Inc's biosimilar to Roche AG's blockbuster treatment for breast cancer, ...
  2. FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharm

    Samsung Bioepis-Merck biosimilar to Roche's Herceptin wins FDA nod

    The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, ...
  3. The logo of Celltrion is seen at company's headquarters in Incheon

    US FDA approves first biosimilar to Roche's cancer drug Rituxan

    The U.S. Food and Drug Administration on Wednesday approved Celltrion Inc's Truxima, making it the first biosimilar to Roche Holding AG's Rituxan ...
  4. FILE PHOTO: A Novartis logo is pictured on its headquarters building in Mumbai

    Novartis launches third-to-market Remicade copy in Germany

    Novartis launched a copy of Johnson & Johnson's (J&J) inflammation-fighting Remicade in Germany on Thursday as the Swiss drugmaker aims to catch ...
  5. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis abandons effort for US approval of biosimilar rituximab

    Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory approval for a biosimilar of ...
  6. FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the N

    AbbVie settles Humira biosimilar dispute with Fresenius Kabi

    U.S. drugmaker AbbVie Inc said on Thursday it has settled a patent dispute regarding its Humira biosimilar with Fresenius Kabi Oncology Ltd and ...
  7. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Amgen, Novartis kick off fight for AbbVie blockbuster drug in EU

  8. FILE PHOTO: CEO Schwan of Swiss drugmaker Roche addresses annual news conference in Basel

    Roche steps up efficiency drive to take sting out of biosimilars

    Roche , the world's biggest producer of cancer drugs, is stepping up cost cuts in an efficiency drive made unavoidable by competition from ...
  9. A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stoc

    Europe ready to cash in on cheap copies of AbbVie biotech drug

    U.S. drugmaker AbbVie ABBV.N faces a crunch moment in Europe in mid-October when less-expensive copies of its US$18-billion-a-year biologic drug ...